VivoSim Labs, Inc. (VIVS) Stock Analysis

    $VIVS · HEALTHCARE · BIOTECHNOLOGY

    VivoSim Labs (VIVS), a BIOTECHNOLOGY company, has a market capitalization of about $4.7M and trades at 1.0x trailing earnings.

    Price

    $1.80

    Market cap

    $4.7M

    P/E ratio

    1.0x

    Dividend yield

    —

    About VivoSim Labs, Inc.

    VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. The company is headquartered in San Diego, California.

    How StockWorthy values VIVS

    StockWorthy forecasts VivoSim Labs, Inc.'s revenue, operating profitability, reinvestment (capital expenditure, depreciation and working capital) and unlevered free cash flow, then discounts those cash flows using a normalized cost of capital built from VIVS's size, profitability and balance-sheet risk. Terminal growth is adjusted to reflect the company's mature growth profile rather than a fixed number. The model presents bear, base and bull scenarios, and every key assumption stays transparent and adjustable in the full StockWorthy analysis. Results are educational and not investment advice.

    Related stocks

    Moderna Inc$MRNARegeneron Pharmaceuticals Inc$REGNargenx NV ADR$ARGX

    See VIVS's Fair Value

    Create a free account to view VivoSim Labs, Inc.'s base-case fair value, the bear–bull modeled range, and every assumption behind them. Free accounts include 5 stock valuations per month — plus Advanced DCF models, financial charts, dividends, and peer analysis.

    Create Free AccountSign In